journal article text

Supplementary Figure 4 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

Abstract

mTORC1/2 downstream pathway evaluation in Tera cells</p

    Similar works

    Full text

    thumbnail-image